Sotera Health Company $SHC Stock Holdings Lifted by Irenic Capital Management LP

Irenic Capital Management LP raised its position in shares of Sotera Health Company (NASDAQ:SHC) by 14.8% in the first quarter, Holdings Channel reports. The firm owned 4,359,348 shares of the company’s stock after buying an additional 561,322 shares during the period. Sotera Health accounts for 4.1% of Irenic Capital Management LP’s investment portfolio, making the stock its 5th largest holding. Irenic Capital Management LP’s holdings in Sotera Health were worth $62,513,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. IFP Advisors Inc grew its stake in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after buying an additional 1,371 shares in the last quarter. Rothschild Investment LLC acquired a new position in Sotera Health in the fourth quarter worth approximately $27,000. Root Financial Partners LLC raised its position in Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after acquiring an additional 1,455 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after acquiring an additional 2,935 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in Sotera Health in the fourth quarter valued at approximately $40,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have commented on SHC. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Piper Sandler restated an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. The Goldman Sachs Group started coverage on shares of Sotera Health in a research note on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Barclays upped their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Finally, Weiss Ratings upgraded Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and an average target price of $20.25.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $17.76 on Wednesday. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The firm has a fifty day simple moving average of $16.74 and a 200-day simple moving average of $16.37. The stock has a market capitalization of $5.06 billion, a price-to-earnings ratio of 43.32 and a beta of 1.76. Sotera Health Company has a 1-year low of $11.00 and a 1-year high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. Sotera Health’s revenue was up 10.0% compared to the same quarter last year. During the same period last year, the business posted $0.14 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, sell-side analysts expect that Sotera Health Company will post 0.87 earnings per share for the current year.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 15.36% of the stock is owned by company insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.